Can you provide the last earnings date for ONKURE THERAPEUTICS INC-A?
ONKURE THERAPEUTICS INC-A (OKUR) last reported earnings on 3/12/2026.
NASDAQ:OKUR • US68277Q1058
Past quarterly earnings results for ONKURE THERAPEUTICS INC-A (OKUR), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.99 | -1.18 | 15.75% | 27.74% | - | - | ||
| Q3 2025 | -1.09 | -1.22 | 10.80% | 0.91% | - | - | ||
| Q2 2025 | -1.14 | -1.27 | 10.44% | 28.75% | - | - | ||
| Q1 2025 | -1.19 | -1.49 | 20.09% | 52.40% | - | - | ||
| Q4 2024 | -1.37 | -0.75 | -81.51% | 80.70% | - | - | ||
| Q3 2024 | -1.10 | -1.05 | -4.70% | 80.70% | - | - | ||
| Q2 2024 | -1.60 | -1.02 | -56.86% | 75.38% | - | - | ||
| Q1 2024 | -2.50 | -4.45 | 43.87% | 58.33% | - | - | ||
| Q4 2023 | -7.10 | -5.89 | -20.47% | -26.79% | - | - | ||
| Q3 2023 | -5.70 | -5.83 | 2.21% | -7.55% | - | - | ||
| Q2 2023 | -6.50 | -5.27 | -23.34% | -30.00% | - | - | ||
| Q1 2023 | -6.00 | -6.16 | 2.61% | -13.21% | - | - | ||
| Q4 2022 | -5.60 | -6.13 | 8.62% | -30.23% | - | - | ||
| Q3 2022 | -5.30 | -5.83 | 9.11% | -1.92% | - | - | ||
| Q2 2022 | -5.00 | -5.94 | 15.77% | -16.28% | - | - | ||
| Q1 2022 | -5.30 | -5.54 | 4.37% | 84.77% | - | - | ||
| Q4 2021 | -4.30 | -5.81 | 26.04% | - | - | - | ||
| Q3 2021 | -5.20 | -4.83 | -7.71% | - | - | - | ||
| Q2 2021 | -4.30 | -3.84 | -11.92% | - | - | - | ||
| Q1 2021 | -34.80 | -3.88 | -797.83% | - | - | - | ||
| Q4 2020 | - | - | - | - | ||||
| Q3 2020 | - | - | - | - | ||||
| Q2 2020 | - | - | - | - | ||||
| Q1 2020 | - | - | - | - |
Notes
ONKURE THERAPEUTICS INC-A (OKUR) last reported earnings on 3/12/2026.
ONKURE THERAPEUTICS INC-A (OKUR) beat EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, ONKURE THERAPEUTICS INC-A (OKUR) has beaten EPS estimates in 4 out of 4 releases.